Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Medical Officer sold 3,786 shares at $55.62 ($210,577)
  12. 4 Open-market sale General Counsel and Secretary sold 3,182 shares at $46.78 ($148,854)
  13. 4 Open-market sale Chief Executive Officer sold 10,020 shares at $46.78 ($468,736)
  14. 4 Open-market sale Chief Financial Officer sold 3,708 shares at $46.78 ($173,460)
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Chief Medical Officer sold 3,150 shares at $48.26 ($152,019)
  17. 4 Open-market sale Chief Financial Officer sold 9,869 shares at $48.26 ($476,278)
  18. 4 Open-market sale General Counsel and Secretary sold 3,450 shares at $48.26 ($166,497)
  19. 4 Open-market sale Chief Executive Officer sold 10,349 shares at $48.26 ($499,443)
  20. 4 Open-market sale General Counsel and Secretary sold 2,800 shares at $52.80 ($147,840)

Page 2 of 26 · 502 filings